| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $24.19B | +0.3% |
| Cost of Revenue | $13.83B | -9.2% |
| Gross Profit | $10.36B | +16.5% |
| R&D Expense | $2.91B | -0.2% |
| SG&A Expense | $2.00B | -7.1% |
| Operating Income | $1.71B | +91.5% |
| Interest Expense | $256.4M | +54.9% |
| Pre-tax Income | $1.69B | +24.5% |
| Income Tax | $385.7M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.56B | -18.7% |
| Accounts Receivable | $238.2M | +60.0% |
| Inventory | $158.3M | +50.8% |
| Current Assets | $22.86B | +15.0% |
| Total Assets | $39.55B | +7.5% |
| Current Liabilities | $10.38B | +21.5% |
| Total Liabilities | $17.38B | +11.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.58B | +51.1% |
| Capital Expenditures | $155.0M | +0.7% |
| Investing Cash Flow | -$2.80B | -531.1% |
| Financing Cash Flow | -$613.1M | -131.4% |
| Free Cash Flow | $2.42B | +56.1% |
| +125.6% |
| Net Income | $1.31B | -54.9% |
| EPS (Basic) | $2.13 | -54.7% |
| EPS (Diluted) | $2.10 | -53.9% |
| Stockholders' Equity |
| $22.20B |
| +4.4% |